Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The United States Food and Drug Administration (FDA) has granted approval for the use of rucaparib as a maintenance treatment for adults dealing with recurrent epithelial ovarian, fallopian tube, or Primary Peritoneal Carcinoma / Peritoneal Carcinomatosis. This approval is specifically for those patients who have achieved either a complete or partial response to platinum-based chemotherapy. Notably, this indication encompasses primary peritoneal carcinoma as one of the qualifying histologies, a decision supported by the findings from the phase-3 ARIEL3 trial (1)
The [EMA has a…